Prevention of phlegm formation in air passages by administering EGF-R antagonists

摘要

the lm with the lp covers the management of obstructive pulmonary diseases. more specifically, and the occluded atu00fcdu0151ben egf - r and an antagonist in the production of koktu00falzott with w g with tl and deals with it.tov (bb, the lm with the excessive secretion of tl atu00fcdu0151ben w g s service products kifejlesztu00e9su00e9reu00e9s roz moved by horse and horse r ra procedure also applies to much of the service.in the lungs, the nykok hiperszekru00e9ciu00f3j the epiderm lis t n "vekedu00e9si factor receptor (egf - r) antagonist in g r s with push.the egf - r antagonist antibodies or small szervesmolekula, ellenanyagru00e9sz can be, which is the egfreceptorhoz k "tu0151dik and blocks.the egf - r t antagonist advantage "sena airways in quantities which use r, g akehelysejtek sufficiently in the airways of push.the kehelysejtek degranul ciu00f3ja, which causes the airways ktermelu00e9st w g, with tolhatu00f3.the sign "ltnektekintett agents to screen a vizsg latokat is provided, which akehelysejtek prolifer t g r o ciu00f3j push.